Business

Pure Secures Long-Term Capital to Advance Shareholder Opportunity

Pure Secures Long-Term Capital to Advance Shareholder Opportunity.

articleRegenerative Medical Technology Group Inc.January 28, 20164/company/regenerative-medical-technology-group-inc/news/pure-secures-long-term-capital-to-advance-shareholder-opportunity
Pure Secures Long-Term Capital to Advance Shareholder Opportunity

About this update from Regenerative Medical Technology Group Inc.

[{"type":"text","content":"\n \n \n Pure Secures Long-Term Capital to Advance Shareholder Opportunity\n \n \nPure Secures Long-Term Capital to Advance Shareholder Opportunity\n\nOver $650K in New Capital Financing Supports Buy-Backs Eliminating Toxic Debt and Other Initiatives\n\n \n LAS VEGAS, NV--(Marketwired - Jan 28, 2016) - Pure Hospitality Solutions, Inc. (OTC PINK: PNOW) parent Company of the Central American-Caribbean online travel Agency (OTA) Oveedia (www.Oveedia.com), announced today that the Company has successfully secured long-term capital financing north of $650K -- with the primary focus being on the immediate start of the Debt Repurchase Program, to eliminate the Company's toxic debts.\n \"We are determined to build shareholder confidence by both growing the most prominent online travel agency in Central America and structurally positioning Pure Hospitality Solutions for optimal growth,\" stated Melvin Pereira, President and CEO of Pure Hospitality Solutions, Inc. \"A financing of this type is just the beginning of ongoing capital infusions, which will help us repurchase and retire toxic debt, refinance other debt obligations, operate the Company more efficiently, and most of all... push Oveedia into the forefront of the Latin American travel industry. Using this long-term capital, we will immediately commence our Debt Repurchase Program to buy back toxic securities -- the next phase of our long-term growth strategy.\"\n [For additional information on the other Various Uses for the Long-Term Capital Secured by Pure, please read: The Various Uses for the Long Term Capital]\n Having secured long-term capital financing north of $650K, management indicated that funding will be in stages, but has confirmed receipt of the first portion of those funds. This puts the Company on-track to eliminate toxic notes and substantially reduce the number of noteholders on the Company's books. In short, management is fighting to protect shareholder value.\n Pereira concluded, \"This year is shaping up to be one of the most productive in Pure's history. We have already accomplished a great deal during this first month of the year, with the most prominent being our push to become a fully reporting, completely transparent company. Having secured long-term capital financing north of $650K, the Debt Repurchase Program is our next step... With 2016 being the ...

More updates from Regenerative Medical Technology Group Inc.